131 related articles for article (PubMed ID: 26119198)
1. Q2DSTD NMR deciphers epitope-mapping variability for peptide recognition of integrin αvβ6.
Sorge JL; Wagstaff JL; Rowe ML; Williamson RA; Howard MJ
Org Biomol Chem; 2015 Aug; 13(29):8001-7. PubMed ID: 26119198
[TBL] [Abstract][Full Text] [Related]
2. Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands.
Maltsev OV; Marelli UK; Kapp TG; Di Leva FS; Di Maro S; Nieberler M; Reuning U; Schwaiger M; Novellino E; Marinelli L; Kessler H
Angew Chem Int Ed Engl; 2016 Jan; 55(4):1535-9. PubMed ID: 26663660
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional heteronuclear saturation transfer difference NMR reveals detailed integrin αvβ6 protein-peptide interactions.
Wagstaff JL; Vallath S; Marshall JF; Williamson RA; Howard MJ
Chem Commun (Camb); 2010 Oct; 46(40):7533-5. PubMed ID: 20838674
[TBL] [Abstract][Full Text] [Related]
4. NMR relaxation and structural elucidation of peptides in the presence and absence of trifluoroethanol illuminates the critical molecular nature of integrin αvβ6 ligand specificity.
Wagstaff JL; Rowe ML; Hsieh SJ; DiCara D; Marshall JF; Williamson RA; Howard MJ
RSC Adv; 2012 Nov; 2(29):11019-11028. PubMed ID: 27182435
[TBL] [Abstract][Full Text] [Related]
5. Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3.
Meinecke R; Meyer B
J Med Chem; 2001 Sep; 44(19):3059-65. PubMed ID: 11543674
[TBL] [Abstract][Full Text] [Related]
6. Structural guided scaffold phage display libraries as a source of bio-therapeutics.
Man YK; DiCara D; Chan N; Vessillier S; Mather SJ; Rowe ML; Howard MJ; Marshall JF; Nissim A
PLoS One; 2013; 8(8):e70452. PubMed ID: 23950939
[TBL] [Abstract][Full Text] [Related]
7. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.
Ahn SB; Mohamedali A; Anand S; Cheruku HR; Birch D; Sowmya G; Cantor D; Ranganathan S; Inglis DW; Frank R; Agrez M; Nice EC; Baker MS
J Proteome Res; 2014 Dec; 13(12):5956-64. PubMed ID: 25318615
[TBL] [Abstract][Full Text] [Related]
9. From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands.
Di Leva FS; Tomassi S; Di Maro S; Reichart F; Notni J; Dangi A; Marelli UK; Brancaccio D; Merlino F; Wester HJ; Novellino E; Kessler H; Marinelli L
Angew Chem Int Ed Engl; 2018 Oct; 57(44):14645-14649. PubMed ID: 29660806
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a novel, high affinity and selective αvβ6 integrin RGD-mimetic radioligand.
Hall ER; Bibby LI; Slack RJ
Biochem Pharmacol; 2016 Oct; 117():88-96. PubMed ID: 27501918
[TBL] [Abstract][Full Text] [Related]
11. Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand.
Tomassi S; D'Amore VM; Di Leva FS; Vannini A; Quilici G; Weinmüller M; Reichart F; Amato J; Romano B; Izzo AA; Di Maro S; Novellino E; Musco G; Gianni T; Kessler H; Marinelli L
J Med Chem; 2021 May; 64(10):6972-6984. PubMed ID: 33961417
[TBL] [Abstract][Full Text] [Related]
12. STD and TRNOESY NMR studies for the epitope mapping of the phosphorylation motif of the oncogenic protein beta-catenin recognized by a selective monoclonal antibody.
Megy S; Bertho G; Gharbi-Benarous J; Baleux F; Benarous R; Girault JP
FEBS Lett; 2006 Oct; 580(22):5411-22. PubMed ID: 16996060
[TBL] [Abstract][Full Text] [Related]
13. A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking.
Sowmya G; Khan JM; Anand S; Ahn SB; Baker MS; Ranganathan S
J Struct Biol; 2014 Mar; 185(3):327-35. PubMed ID: 24423664
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the
Roper JA; Wilkinson AL; Gower E; Slack RJ
J Pharmacol Exp Ther; 2021 Feb; 376(2):273-280. PubMed ID: 33318076
[TBL] [Abstract][Full Text] [Related]
15. The roles of integrin αvβ6 in cancer.
Niu J; Li Z
Cancer Lett; 2017 Sep; 403():128-137. PubMed ID: 28634043
[TBL] [Abstract][Full Text] [Related]
16. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.
Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS
J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2.
Slack RJ; Hafeji M; Rogers R; Ludbrook SB; Marshall JF; Flint DJ; Pyne S; Denyer JC
Pharmacology; 2016; 97(3-4):114-25. PubMed ID: 26734728
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.
Fontana L; Chen Y; Prijatelj P; Sakai T; Fässler R; Sakai LY; Rifkin DB
FASEB J; 2005 Nov; 19(13):1798-808. PubMed ID: 16260650
[TBL] [Abstract][Full Text] [Related]
19. Bactrian camel (Camelus bactrianus) integrins alphavbeta3 and alphavbeta6 as FMDV receptors: molecular cloning, sequence analysis and comparison with other species.
Du J; Gao S; Chang H; Cong G; Lin T; Shao J; Liu Z; Liu X; Cai X
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):190-9. PubMed ID: 19443046
[TBL] [Abstract][Full Text] [Related]
20. High integrin α
Dong X; Zhao B; Lin FY; Lu C; Rogers BN; Springer TA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1429-E1436. PubMed ID: 29378937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
